News dal mondo

10

Ago

EMA issues updated guidance on shortage prevention plans ahead of legal deadline

The European Medicines Agency (EMA) has issued an updated guideline to assist marketing authorisation holders (MAHs) to create and maintain drug shortage prevention plans (SPPs) for their products.

MAHs must submit these plans to national competent authorities upon request and are required to implement them by mid-2027 under the new EU pharmaceutical legislation.

The agency explained that the goal of the SPPs is to identify vulnerabilities within medicine supply chains and ensure that appropriate measures are in place to prevent, mitigate, or manage any risks that could lead to shortages...[EMA - RAPS]

10

Ago

Wise Equity investe in E-Pharma Trento

Wise Equity, società di gestione del fondo Wisequity VI, e Unifarm, azionista unico...

03

Ago

Destiniamo parte dei fondi per la difesa alla produzione di farmaci fuori brevetto

Le “montagne russe” provocate dalla violenta ma ondivaga politica sui dazi di Trump e sui...

31

Lug

FDA unveils FY 2027 user fee rates

The US Food and Drug Administration (FDA) has published its user fee rates for FY 2027 across its prescription...

29

Lug

Esenzione sui dazi per taluni prodotti provenienti dagli USA

Il 25 giugno 2026 è stato pubblicato il REGOLAMENTO (UE) 2026/1455 DEL PARLAMENTO EUROPEO E DEL...